403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Satellos Bioscience Inc.
(MENAFN- Baystreet) 10:22 AM EST - Satellos Bioscience Inc.: Announced financial results and corporate highlights for the full year ended Dec. 31, 2025. For the year ended Dec. 31, 2025, Satellos reported a net loss of $24.9 million ($1.70 loss per basic and diluted common share), compared to a net loss of $20.6 million ($2.16 loss per basic and diluted common share) for the year ended Dec. 31, 2024. Satellos Bioscience Inc.
shares T are trading down $0.57 at $9.03.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
Comments
No comment